Evidence map›Paper›PMID 31205025›Full record

ArticleThe Journal of clinical investigation2019

Chaperone protein HSC70 regulates intercellular transfer of Y chromosome antigen DBY.

Sascha Kretschmann, Stefanie Herda, Heiko Bruns, Josefine Russ, Edith D van der Meijden, Ursula Schlötzer-Schrehardt, Marieke Griffioen, Il-Kang Na, Andreas Mackensen, Anita N Kremer

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sascha KretschmannDepartment of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Stefanie HerdaExperimental and Clinical Research Center, Berlin, Germany.
Heiko BrunsDepartment of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Josefine RussExperimental and Clinical Research Center, Berlin, Germany.
Edith D van der MeijdenDepartment of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Ursula Schlötzer-SchrehardtDepartment of Ophthalmology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Marieke GriffioenDepartment of Hematology, Leiden University Medical Center, Leiden, Netherlands.
Il-Kang NaExperimental and Clinical Research Center, Berlin, Germany.
Andreas MackensenDepartment of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Anita N KremerDepartment of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEHumboldt-Universität zu Berlin · DELeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have demonstrated that CD4+ T cells can efficiently reject MHC-II-negative tumors. This requires indirect presentation of tumor-associated antigens on surrounding antigen-presenting cells. We hypothesized that intercellular transfer of proteins is not the sole consequence of cell death-mediated protein release, but depends on heat-shock cognate protein 70 (HSC70) and its KFERQ-like binding motif on substrate proteins. Using human Y chromosome antigen DBY, we showed that mutation of one of its 2 putative binding motifs markedly diminished T cell activation after indirect presentation and reduced protein-protein interaction with HSC70. Intercellular antigen transfer was shown to be independent of cell-cell contact, but relied on engulfment within secreted microvesicles. In vivo, alterations of the homologous KFERQ-like motif in murine DBY hampered tumor rejection, T cell activation, and migration into the tumor and substantially impaired survival. Collectively, we show that intercellular antigen transfer of DBY is tightly regulated via binding to HSC70 and that this mechanism influences recognition and rejection of MHC-II-negative tumors in vivo.

Indexed as

Amino Acid MotifsAnimalsDEAD-box RNA HelicasesHeLa CellsHistocompatibility Antigens Class IIHSC70 Heat-Shock ProteinsHumansLymphocyte ActivationMCF-7 CellsMiceMinor Histocompatibility AntigensNeoplasm ProteinsNeoplasmsProtein TransportSecretory VesiclesT-LymphocytesDDX3Y protein, humanDdx3y protein, mouseDEAD-box RNA HelicasesHistocompatibility Antigens Class IIHSC70 Heat-Shock ProteinsHSPA8 protein, humanHspa8 protein, mouseMinor Histocompatibility AntigensNeoplasm ProteinsAntigen presentationCancer immunotherapyImmunologyOncologyT cells

Identifiers

PMID31205025
PMCPMC6597200
OpenAlexW2949237243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.